U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Grade 4 Hemorrhoids, CTCAE

MedGen UID:
327238
•Concept ID:
C1560454
•
Finding

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGrade 4 Hemorrhoids, CTCAE

Recent clinical studies

Etiology

Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial.
See AW, Bowden P, Wells G, Appu S, Lawrentschuk N, Liodakis P, Pandeli C, Aarons Y, Smyth LML, McKenzie DP
Radiat Oncol 2022 Jul 25;17(1):131. doi: 10.1186/s13014-022-02103-5. PMID: 35879722Free PMC Article
Outcomes of Squamous Cell Carcinoma Anal Canal treated with IMRT-VMAT-based Concurrent Chemoradiation: a Single Institutional Experience.
Singh K, Sathyamurthy A, Ramireddy JK, Ram TS
J Gastrointest Cancer 2022 Mar;53(1):161-169. Epub 2021 Jan 5 doi: 10.1007/s12029-020-00580-z. PMID: 33400211
Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 study.
Chapet O, Udrescu C, Bin S, Decullier E, Fenoglietto P, Beneux A, Segui B, Enachescu C, Gaudioz S, Ruffion A, Azria D
Br J Radiol 2021 Aug 1;94(1124):20210242. doi: 10.1259/bjr.20210242. PMID: 34282946Free PMC Article
Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.
Takakusagi Y, Katoh H, Kano K, Anno W, Tsuchida K, Mizoguchi N, Serizawa I, Yoshida D, Kamada T
Radiat Oncol 2020 May 27;15(1):127. doi: 10.1186/s13014-020-01575-7. PMID: 32460889Free PMC Article
Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
Simha V, Rai B, Patel FD, Kapoor R, Sharma SC, Singh OA, Singla V, Dhanireddy B, Ghoshal S
Brachytherapy 2018 Mar-Apr;17(2):345-351. doi: 10.1016/j.brachy.2017.09.008. PMID: 29102740

Diagnosis

Evaluating the Incidence Rate of an Accelerated Short Course High Dose Rate Intravaginal Brachytherapy Complications in Patients with Endometrial Cancer.
Amouzegar Hashemi F, Vesgari Kiasari Z, Kalaghchi B, Aghili M, Gholami S, Mansouri S, Moalej S, Maddah Safaei A
Asian Pac J Cancer Prev 2019 Jul 1;20(7):2039-2043. doi: 10.31557/APJCP.2019.20.7.2039. PMID: 31350963Free PMC Article
Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life.
Moman MR, van der Heide UA, Kotte AN, van Moorselaar RJ, Bol GH, Franken SP, van Vulpen M
Radiother Oncol 2010 Jul;96(1):38-42. Epub 2010 Mar 23 doi: 10.1016/j.radonc.2010.02.027. PMID: 20334942
Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
van der Laan HP, van den Bergh A, Schilstra C, Vlasman R, Meertens H, Langendijk JA
Int J Radiat Oncol Biol Phys 2008 Mar 15;70(4):1138-45. Epub 2007 Oct 10 doi: 10.1016/j.ijrobp.2007.07.2363. PMID: 17931794

Therapy

Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial.
See AW, Bowden P, Wells G, Appu S, Lawrentschuk N, Liodakis P, Pandeli C, Aarons Y, Smyth LML, McKenzie DP
Radiat Oncol 2022 Jul 25;17(1):131. doi: 10.1186/s13014-022-02103-5. PMID: 35879722Free PMC Article
Outcomes of Squamous Cell Carcinoma Anal Canal treated with IMRT-VMAT-based Concurrent Chemoradiation: a Single Institutional Experience.
Singh K, Sathyamurthy A, Ramireddy JK, Ram TS
J Gastrointest Cancer 2022 Mar;53(1):161-169. Epub 2021 Jan 5 doi: 10.1007/s12029-020-00580-z. PMID: 33400211
Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 study.
Chapet O, Udrescu C, Bin S, Decullier E, Fenoglietto P, Beneux A, Segui B, Enachescu C, Gaudioz S, Ruffion A, Azria D
Br J Radiol 2021 Aug 1;94(1124):20210242. doi: 10.1259/bjr.20210242. PMID: 34282946Free PMC Article
Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.
Takakusagi Y, Katoh H, Kano K, Anno W, Tsuchida K, Mizoguchi N, Serizawa I, Yoshida D, Kamada T
Radiat Oncol 2020 May 27;15(1):127. doi: 10.1186/s13014-020-01575-7. PMID: 32460889Free PMC Article
Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
Simha V, Rai B, Patel FD, Kapoor R, Sharma SC, Singh OA, Singla V, Dhanireddy B, Ghoshal S
Brachytherapy 2018 Mar-Apr;17(2):345-351. doi: 10.1016/j.brachy.2017.09.008. PMID: 29102740

Prognosis

Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial.
See AW, Bowden P, Wells G, Appu S, Lawrentschuk N, Liodakis P, Pandeli C, Aarons Y, Smyth LML, McKenzie DP
Radiat Oncol 2022 Jul 25;17(1):131. doi: 10.1186/s13014-022-02103-5. PMID: 35879722Free PMC Article
Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.
Takakusagi Y, Katoh H, Kano K, Anno W, Tsuchida K, Mizoguchi N, Serizawa I, Yoshida D, Kamada T
Radiat Oncol 2020 May 27;15(1):127. doi: 10.1186/s13014-020-01575-7. PMID: 32460889Free PMC Article
Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
Simha V, Rai B, Patel FD, Kapoor R, Sharma SC, Singh OA, Singla V, Dhanireddy B, Ghoshal S
Brachytherapy 2018 Mar-Apr;17(2):345-351. doi: 10.1016/j.brachy.2017.09.008. PMID: 29102740
Proctitis following stereotactic body radiation therapy for prostate cancer.
Joh DY, Chen LN, Porter G, Bhagat A, Sood S, Kim JS, Moures R, Yung T, Lei S, Collins BT, Ju AW, Suy S, Carroll J, Lynch JH, Dritschilo A, Collins SP
Radiat Oncol 2014 Dec 12;9:277. doi: 10.1186/s13014-014-0277-4. PMID: 25497602Free PMC Article
Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature.
Fakhrian K, Sauer T, Dinkel A, Klemm S, Schuster T, Molls M, Geinitz H
Strahlenther Onkol 2013 Jun;189(6):486-94. Epub 2013 May 2 doi: 10.1007/s00066-013-0314-5. PMID: 23636349

Clinical prediction guides

Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial.
See AW, Bowden P, Wells G, Appu S, Lawrentschuk N, Liodakis P, Pandeli C, Aarons Y, Smyth LML, McKenzie DP
Radiat Oncol 2022 Jul 25;17(1):131. doi: 10.1186/s13014-022-02103-5. PMID: 35879722Free PMC Article
Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 study.
Chapet O, Udrescu C, Bin S, Decullier E, Fenoglietto P, Beneux A, Segui B, Enachescu C, Gaudioz S, Ruffion A, Azria D
Br J Radiol 2021 Aug 1;94(1124):20210242. doi: 10.1259/bjr.20210242. PMID: 34282946Free PMC Article
Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.
Takakusagi Y, Katoh H, Kano K, Anno W, Tsuchida K, Mizoguchi N, Serizawa I, Yoshida D, Kamada T
Radiat Oncol 2020 May 27;15(1):127. doi: 10.1186/s13014-020-01575-7. PMID: 32460889Free PMC Article
Proctitis following stereotactic body radiation therapy for prostate cancer.
Joh DY, Chen LN, Porter G, Bhagat A, Sood S, Kim JS, Moures R, Yung T, Lei S, Collins BT, Ju AW, Suy S, Carroll J, Lynch JH, Dritschilo A, Collins SP
Radiat Oncol 2014 Dec 12;9:277. doi: 10.1186/s13014-014-0277-4. PMID: 25497602Free PMC Article
Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature.
Fakhrian K, Sauer T, Dinkel A, Klemm S, Schuster T, Molls M, Geinitz H
Strahlenther Onkol 2013 Jun;189(6):486-94. Epub 2013 May 2 doi: 10.1007/s00066-013-0314-5. PMID: 23636349

Supplemental Content

Table of contents

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...